Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-06-08

FDA Approved: BACLOFEN — Original Application (Slayback Pharma LLC)

View source ↗

Summary

The FDA approved Slayback Pharma LLC's original application for a generic baclofen product for the treatment of spasticity associated with multiple sclerosis an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BACLOFEN (Baclofen)

Snippet

ORIG AP for BACLOFEN (BACLOFEN)